Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

324.71 +0.48 (+0.15%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Eli Lilly: Q2 Earnings Insights
Shares of Eli Lilly (NYSE:LLY) decreased 1.3% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 1.06% over the... 
Via Benzinga
Lilly Stock Slips On Mixed Bag Q2 Earnings, Cuts FY21 Sales Outlook For COVID-19 Therapies
Eli Lilly And Co (NYSE: LLY) posted Q2 sales of $6.74 billion, beating the consensus of $6.65 billion and an increase of 23% Y/Y, Higher sales were driven by a 22... 
Via Benzinga
Exposures COVID-19
Eli Lilly Earnings Fall Short, Sales Top; LLY Stock Falls Slightly
Eli Lilly earnings slightly missed Q2 estimates, though the drug giant's sales edged past views. LLY stock dipped. 
Via Investor's Business Daily
A Peek Into The Markets: US Stock Futures Gain Ahead Of Earnings
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones dropped around 100 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
Topics Stocks
Exposures US Equities
5 Stocks To Watch For August 3, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Alibaba Group Holding Ltd - ADR (NYSE: BABA) to report quarterly earnings at $2.24 per share on... 
Via Benzinga
Week In Review: Kumquat Signs $2 Billion US-China Deal With Lilly For Novel Immune Drugs
Kumquat Biosciences announced a $2 billion agreement with a Lilly subsidiary to discover small molecule drugs that stimulate tumor-specific immune responses in cancer patients. Lilly will make a $70... 
Via Talk Markets
Cummins Joins Call for Congressional Action Protecting Dreamers
Cummins Joins Call for Congressional Action Protecting Dreamers 
Via News Direct
Topics Immigration
Exposures COVID-19 Immigration
Lilly's Donanemab Lowers Alzheimer's-Associated Biomarkers In Patients With Early Disease
Eli Lilly And Co (NYSE: LLY) rolled out the new exploratory analyses of the Trailblazer Phase 2 trial at the Alzheimer's Association International Conference.... 
Via Benzinga
Eli Lilly-Incyte's Rheumatoid Arthritis Drug Gets OK From FDA For Solo Use In Hospitalized COVID-19 Patients
The FDA extended the Emergency Use Authorization (EUA) for Eli Lilly And Co's (NYSE: LLY) and Incyte Corporation's (NASDAQ: INCY) rheumatoid... 
Via Benzinga
Exposures COVID-19 Product Safety
Lilly, Kumquat Biosciences Team Up To Discover, Develop Immuno-Oncology Candidates
Loxo Oncology, a unit of Eli Lilly And Co (NYSE: LLY), and Kumquat Biosciences have announced an exclusive collaboration to discover, develop, and... 
Via Benzinga
Banned Merger
Today stock markets are in disarray after the full horror of Beijing's attack on Chinese capitalism has been understood. 
Via Talk Markets
Why Annovis Stock Is Bucking The Trend In Alzheimer's — And Two Others To Watch
Annovis bucked the trend depressing Alzheimer's stocks on Friday as ANVS stock touched a record high while SAVA stock and INMB stock fell. 
Via Investor's Business Daily
Five-Year Compounded Value of Eli Lilly Holdings
The Power of the Dividend In a world obsessed with price movements of stocks, it's easy to lose sight of what those prices represent -- the value of holding a company's future... 
Via Benzinga
2 Compelling Reasons to Buy This Reawakened Pharma Giant
The attention of the world over the next month could bring higher revenue for years to come. 
Via The Motley Fool
Topics Death
Exposures Death
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI... 
Via Benzinga
Stocks That Hit 52-Week Highs On Friday
On Friday morning, 126 companies achieved new highs for the year. Significant Points: Microsoft (NASDAQ:MSFT) was the largest firm on a market cap basis to set a... 
Via Benzinga
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (... 
Via Benzinga
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears,... 
Via Talk Markets
Exposures Product Safety
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week... 
Via Benzinga
Exposures Product Safety
Could Eli Lilly Successfully Treat Heart Failure With Its Diabetes Drug?
Based on the company's late-stage results for Jardiance, the answer appears to be a resounding "yes." 
Via The Motley Fool
AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA
AbbVie Inc (NYSE: ABBV) and Eli Lilly And Co (NYSE: LLY) will have to keep waiting for a chance for their JAK inhibitors in atopic dermatitis to see the market.... 
Via Benzinga
Unusual Options Activity Insight: Eli Lilly
Shares of Eli Lilly (NYSE:LLY) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to $232.81. Sentiment: NEUTRAL... 
Via Benzinga
Biogen Stock And The Aduhelm Drama: Will It Really Treat Alzheimer's?
The fate of Biogen stock is now intricately tied to the success — or failure — of its controversial Alzheimer's treatment, Aduhelm. 
Via Investor's Business Daily
The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical... 
Via Benzinga
Eli Lilly Scoops Up Protomer Technologies In Over $1B Deal
Eli Lilly And Co (NYSE: LLY) has acquired privately-held biotech firm Protomer Technologies in a deal valued at more than $1 billion. Lilly previously... 
Via Benzinga
Eli Lilly's Mirikizumab Shows Mucosal Healing In Ulcerative Colitis Maintained For Up To One Year
Eli Lilly And Co (NYSE: LLY) has announced new Phase 2 data showing that gene expression changes induced by mirikizumab in patients with ulcerative colitis (UC) over a... 
Via Benzinga
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc... 
Via Benzinga
Biogen Stock Pops Despite New FDA Limits On Alzheimer's Drug Use
Biogen stock rose Thursday after the Food and Drug Administration signed off on narrower recommendations for Alzheimer's drug Aduhelm. 
Via Investor's Business Daily
Exposures Product Safety
Eli Lilly, Verge Genomics Ink $720M Pact For Amyotrophic Lateral Sclerosis Therapies
Verge Genomics has announced a three-year collaboration with Eli Lilly And Co (NYSE: LLY) to research and develop novel therapies to treat amyotrophic lateral... 
Via Benzinga
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... 
Via Benzinga
Topics Product Recall
Exposures COVID-19 Legal Product Safety
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.